About
Technology
Issues
FAQ
Links
Official Page
A randomised, placebo-controlled phase 3 study to evaluate the efficacy and safety of ASP0113, a DNA-based CMV vaccine, in seropositive allogeneic haematopoietic cell transplant recipients
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.